An update on contraceptive therapy options

American Journal of Therapeutics
Mitzi Wasik

Abstract

The introduction of new contraception formulations and different routes of administration offers women more options when choosing birth control methods. Despite new options, there are still risks to consider when prescribing contraception to women on an individual basis. In the past 5 years alone, there has been the introduction of extended and continuous cycle oral contraceptives, a new subdermal implant, and shorter hormone-free intervals in 28-day cycles. Cardiovascular risks including stroke, myocardial infarction, and venous thromboembolism are risks that must still be considered in certain populations. In 2005, the Food Drug and Administration issued a press release concerning the higher exposure to estrogen in the transdermal patch compared with 35-μg oral contraceptives. This statement led to concerns of serious adverse events. Women who have no contraindications for contraception continue to struggle with adherence to daily, weekly, and even monthly regimens. Patients must take responsibility for taking their contraception as scheduled or risk becoming pregnant. The relationship of weight and efficacy of combined hormonal contraception is a concern that many health care practitioners have, and unfortunately, the data a...Continue Reading

References

May 1, 1995·The Journal of Reproductive Medicine·M J RosenbergS Long
Jun 17, 1995·Lancet·P G McIntyre
May 21, 1999·The American Journal of Medicine·F GrodsteinM J Stampfer
Mar 4, 2000·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·M K DuC H Chen
Jun 29, 2000·JAMA : the Journal of the American Medical Association·L A GillumS C Johnston
Jul 7, 2001·BMJ : British Medical Journal·J E Cohen
Jul 19, 2002·JAMA : the Journal of the American Medical Association·Jacques E RossouwUNKNOWN Writing Group for the Women's Health Initiative Investigators
Dec 10, 2002·CA: a Cancer Journal for Clinicians·Debbie SaslowUNKNOWN American Cancer Society
Mar 26, 2003·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Irving Sivin
Apr 11, 2003·Lancet·Jennifer S SmithValerie Beral
Jul 25, 2003·Contraception·Yousef S KhaderOsama Abueita
Sep 5, 2003·Contraception·F D Anderson, Howard Hait
Jul 1, 1963·The Journal of New Drugs·A SINGH, V P LAKHANPAL
Apr 14, 2004·Archives of Internal Medicine·Wee-Shian ChanJeffrey S Ginsberg
Apr 24, 2004·American Journal of Obstetrics and Gynecology·Ronald BurkmanMiriam Zieman
Jul 21, 2004·Lancet Neurology·Leslie A Gillum, S Claiborne Johnston
Oct 16, 2004·Drugs·Inka Wiegratz, Herbert Kuhl
Mar 1, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Roger L MilneAlice S Whittemore
Jun 18, 2005·American Journal of Epidemiology·Julia B GreerRoberta B Ness
Aug 13, 2005·The Lancet Oncology·Vincent CoglianoUNKNOWN WHO International Agency for Research on Cancer
Sep 2, 2005·Obstetrics and Gynecology·Kimberly A YonkersAndrea Rapkin
Oct 20, 2005·Maternal and Child Health Journal·Larissa R Brunner Huber, Carol J Hogue
Mar 7, 2006·Annals of Epidemiology·Larissa R Brunner HuberMiriam Zieman
May 2, 2006·American Journal of Obstetrics and Gynecology·Larissa R Brunner HuberSusan Schayes
Jun 2, 2006·Obstetrics and Gynecology·UNKNOWN ACOG Committee on Practice Bulletins-Gynecology
Oct 24, 2006·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Medard M Lech, Lucyna Ostrowska
Dec 13, 2006·Contraception·David F ArcherGinger D Constantine
Feb 3, 2007·Obstetrics and Gynecology·J Alexander ColeAlexander M Walker
Mar 3, 2007·Obstetrics and Gynecology·Galina LurieMarc T Goodman
Jun 15, 2007·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Francisca Martínez, Angels Avecilla
Jul 28, 2007·American Journal of Epidemiology·Shelley S TworogerSusan E Hankinson
Sep 6, 2007·American Journal of Epidemiology·Larissa R Brunner Huber, Jessica L Toth
Nov 6, 2007·Clinical Obstetrics and Gynecology·Heather Hohmann, Mitchell D Creinin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.